Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis.
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
A D
AD
Wechalekar
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
C
C
Whelan
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D009202:Cardiomyopathies / Q000188:drug therapy / Q000401:mortality; D018572:Disease-Free Survival; D004318:Doxycycline / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis / Q000188:drug therapy / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate
D004318:Doxycycline